2008 2 223 WHO 2 20042 025-85478032 025-85478032 www.ncstdc.org 2007 2007 3 2007 6 CDC CIPRA 8 3 2008 4 0 4 4 5 2008 6 6 6
2007 987 (GRSP)992 WPRO Gonococcal Antibiotics Susceptibility Programme, GASP 2007 200758 25 29 2007 2008 2007 3 63 68 200 9 3 00 62 08 / CDC 202 23 56 8 44 60 2007 3 63 2 TRNG PPNG 23 0 23 2 6 5 47 76 72 39 202 0 202 202 46 56 80 72 200 0 200 96 4 74 26 84 97 68 0 68 67 49 9 4 9 08 0 08 04 4 3 95 38 39 44 0 44 44 20 24 24 4 62 0 62 62 36 26 8 0 00 0 00 69 22 9 2 88 30 33 60 59 59 2 39 7 23 56 0 56 56 55 40 40 8 0 8 5 3 6 02 38 55
TRNG PPNG 3 0 3 3 8 5 2 3 9 0 9 9 5 4 4 63 62 08 4 4 448 75 488 435 (%) 0. 99.9 95.3 3.5.2 38.5 6.5 42.0 37.4 2 200-2007 % PPNG TRNG 200 3.9 29.04 89.80 0.37 0 2002 34.72 3.4 92.47 0.2 0.2 2003 47.7 35.2 94.2 0.2 0 2004 37.4 25.5 95.7 0. 0 2005 48.8 34. 94.3 0.2 0 2006 35.5 32. 93.4 0.0 0.3 2007 37.4 42.0 95.3 0. 0 200~2007 PPNG TRNG 37.4% 42.0% 95% 52% 2008 2
,,,, 2007-20 2 CDC 76 3 5 250ul WHO 4 80% 5 80% 0% 0% 20 0 5 00 90 80-89 60-79 <60 2007 29 46 42 34 00 9099 8089 6079 80 (%)* 0(34.45) 7(24.4) 9(3.03) 3(0.34) 26(89.66) (%) 8(38.3) 5(3.9) 8(7.02) 6(2.77) 4(87.23) (%) 4(33.33) (26.9) 3(30.95) 4(9.52) 38(90.48) (%) 4(4.8) (32.35) 4(.76) 5(4.7) 29(85.29) * 22007 2 2 2007 (%) (%) (%) 98.40 87.20 97.07 32007 3 3
3 2007 (%) (TRUST) (RPR) ()(TPPA) ()(ELISA-TP) ()(TPHA) * 75 68.00 32.00 89.33 8.0.33.33 5 24 67 6 42007 45 4 2007 TRUST RPR TPPA TPHA ELISA 98.43 90.98 98.33 79.2 98.8 00 85.7 00 5 2007 2 (%) (%) (%) TPPA 67 98.8 TRUST 45 99. 9.56 ELISA 3 88.89 TRUST2 3 86.67 86.67 ELISA 2 00.00 TRUST3 2 00.00 80.00 ELISA 3 00.00 TRUST4 00.00 00.00 ELISA 4 00.00 RPR 24 98.33 79.2 TPHA 00.00 00.00 52007 6 6 2007 2 2 6 3 2 8 3 3 2 9 6 5 5 2 8 2 2 ( 6.89%), 2 (4.37%), 7 (24.3%). 4
5 (0.86%), 22(47.82%), 2 (4.34%).60 76 42 80 38 90.48% 29 80 26 89.66% 2 RPR TRUST EIA, 3. 2006 50% 4. 5
2007 2007 5 CDC 2006 (CT) CT 3 73 E ATCC 2 E 50µl37 4h4 2 3 5 2 4 5 6 20 0 00 00 80 60 <60 47.9% 35 37.0%27 9.6%7 5.5%4 73 47.935/73 37.027/73 9.67/73 5.54/73 73 2 PCR-ELISAEIA 3 7 9.8% 6.8% EIA.4% PCR 2CT 6 2 EIA PCR 67 5 9.8 6.8.4 CT
76 CT 73 3 CDC2 CDC CDC CDC 2 3 4 2 07004 07005 07003 PCR EIA 07004 07005 5 90.489.067.90.49.8 3 2007 73 5 () 0700 66 90.4 07002 65 89.0 07003 49 67. 07004 65 89.0 07005 67 9.8 3 9 CT 4 6.6 38.4 4 4 45 28 6.6 38.4 73 00.0 5 3 2 5 5 3 CT 5 3.32/5 86.73/5 2 3 53.87/3 46.26/3 37 64.924/37 35.3/37 CT CT 7
CT CT 2002-2007 CIPRAChina Integrated Programs for Research on AIDS 5 500 5 4 24 3 2 2 5 2 CIPRA CDC C 2 C 8
2 CIPRA RPR TPPA FUJIREBIO INCJAPAN Amplication CT/NGTestRoche USA Amplication CT/NGTestRoche USA -2 ELISA HerpeSelect-2ELISAIgG FOCUSUSA 3. 2 20.2 HSV-2 3 2003.7 CDC 2003. CDC 2003. CDC 2004.6 CDC 2 2 2004.8 CDC 2 2 2004.0 CDC CDC CDC 2 2005.4 CDC CDC CDC 3 2005.0 CDC CDC CDC 2 2006.3 CDC CDC HSV-2 2 2006.4 CDC 2006.9 CDC CDC 2 CDC 2007.3 CDC CDC CDC 2 20 2 4 2. 9
2.. 4 2 SOP 2..2 2.2 6 CT/NG HSV-2 4 2003.9 3 2004.8 27 2004. \\\ CDC 2 2005.4 CDC 24 2006. HSV-2 CDC 2 2006. CT/NG CDC 2 2006.2-30 2006.9-28 28 3 3. HSV-2-ELISACT/NG TV NIH 5/ 3.2 / SOP 5 ( ) 0
2004 2007 27473 6.54/0 30.8% 2007 2007 5-2007 2 3 53 38 50 48 34 57 3 23 68 53 2 0 4 4 2 2 2-7 2 VDRL
% % % () () () () % 23(60.5) 2(42.0) 26(54.) 0074.6 40(70.2) 82(72.6) 9(39.) 56(82.4) 357(67.2) 5(39.5) 26(52.0) 22(45.8) 27(20.) 7(29.8) 3(27.4) 0(43.5) (6.2) 59(29.9) 38 50 48 34 57 3 23 68 53 3 % % % () () () () % 2(55.3) 23(46.0) 28(58.3) 58(43.3) 3459.6 696. 5(2.7) 56(82.4) 294(55.4) 7(44.7) 26(52.0) 9(39.6) 72(53.7) 2340.4 5246 8(78.3) 0(4.7) 237(44.6) 38 50 48 34 57 3 23 68 53 4 % % % () () () () % 33(86.8) 42(84) 44(9.6) 0(82.) 55(96.5) 03(9.2) 2(9.3) 59(86.7) 467(87.9) 4(0.5) 8(6) 3(6.3) 20(4.9) 2(3.5) 0(4.3) (4.3) 6(8.8) 54(0.2) 38 50 48 34 57 3 23 68 53 5 RPR+/TPPA- % % % () () () () % 30(79.0) 47(94.0) 44(9.7) 22(9.0) 56(98.2) 09(96.5) 6(69.6) 64(94.) 488(9.9) 8(2.0) 2(4.0) 3(6.3) 2(9.0) (.8) 4(3.5) 7(30.4) 2(2.9) 39((7.3) 38 50 48 34 57 3 23 68 53 6 % % % () () () () % A 9(23.6) 8(36.0) 6(3.3) 38(28.4) 23(40.4) 8(5.9) 3(56.5) 23(33.8) 48((27.8) B (28.9) 3(26.0) 3(27.) 56(4.2) 5(26.3) 56(49.6) 5(78.3) 9(27.9) 98(37.2) C 25(65.8) 3(62.0) 43(89.6) 98(73.) 49(86.0) 03(96.5) 8(34.7) 58(85.3) 45(78.2) D 9(23.7) 2(4.0) 4(8.3) 24(7.9) 7(2.3) 2(.8) (47.8) (.4) 60(.3) 38 50 48 34 57 3 23 68 53 2 A: TPPA B: 00%
C: TPPA D: RPR C 2008 3 4~6 CDC Rosanna Peeling Myron Cohen 6 FHI DFID/CHARTS/GFAIDS R4 3
2008 6~ 30 25% 42.9% 7.9% 4.3% / 2008 3 6~2 7 8 4
9 TRUST TPPA ELISA HIV 99% 60.3 84.3 2007 6 5
(2006-200 ) 2008 / 2008 0, HSV HIV 000 9 025-85478080 025-8547895 025-85478080 E-mail:shimq6@yahoo.com.cnfanly80@yeah.net 6
7